Calabrese brings decades of health-system pharmacy leadership, deep experience in pharmacy training accreditation, and a longstanding commitment to ASHP's mission and the profession. He currently ...

Calabrese will become ASHP’s fifth CEO in its 84-year history, succeeding longtime CEO Paul W. Abramowitz, who retired ...

The American Society of Health-System Pharmacists has appoin t ed Samuel Calabrese as executive vice president and CEO, effective May 1. Mr. Calabrese will become the fifth CEO in the organization’s ...

The American Society of Health-System Pharmacists (ASHP) is working to end a practice known as "white bagging," officials said. White bagging is when a payer mandates that providers can only source ...

ASHP noted that the draft rule includes several concerning proposals that would reduce Medicare funding for patient care services. The proposed rule also includes provisions addressing the elimination ...

The American Society of Health-System Pharmacists matched 3,872 individuals with 1,567 pharmacy residency programs in phase 1 of its 2026 Pharmacy Residency Match. An additional 764 postgraduate first ...

BETHESDA, Md. -- ASHP (American Society of Health-System Pharmacists) today announced the publication of two landmark reports that articulate a futuristic vision for pharmacy practice, including ...

CARY, N.C., July 20, 2023 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee), a Cary-based specialty pharmaceutical company, announced today that Jon Zwinski, CEO and General Manager at Chiesi USA, has ...

The American Society of Health-System Pharmacists (ASHP) believes that the widespread, indiscriminate use of dietary supplements presents substantial risks to public health and that pharmacists have ...

The 2014 ASHP (American Society of Health-System Pharmacists) Midyear Clinical Meeting and Exhibition, held Dec. 7–11 at the Anaheim Convention Center, brought together the pharmaceutical community ...

BETHESDA, Md., March 19, 2026 /PRNewswire/ -- The ASHP Board of Directors today announced the appointment of Samuel V. Calabrese, BSPharm, MBA, FASHP, CPEL, as executive vice president and CEO, ...